↓ Skip to main content

Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803

Overview of attention for article published in Clinical Cancer Research, January 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
240 Dimensions

Readers on

mendeley
129 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803
Published in
Clinical Cancer Research, January 2012
DOI 10.1158/1078-0432.ccr-11-2246
Pubmed ID
Authors

Shuji Ogino, Kaori Shima, Jeffrey A. Meyerhardt, Nadine J. McCleary, Kimmie Ng, Donna Hollis, Leonard B. Saltz, Robert J. Mayer, Paul Schaefer, Renaud Whittom, Alexander Hantel, Al B. Benson, Donna Spiegelman, Richard M. Goldberg, Monica M. Bertagnolli, Charles S. Fuchs

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 129 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Ecuador 2 2%
Spain 1 <1%
Unknown 126 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 25 19%
Student > Ph. D. Student 16 12%
Student > Bachelor 14 11%
Student > Postgraduate 13 10%
Other 11 9%
Other 29 22%
Unknown 21 16%
Readers by discipline Count As %
Medicine and Dentistry 64 50%
Agricultural and Biological Sciences 16 12%
Biochemistry, Genetics and Molecular Biology 13 10%
Nursing and Health Professions 3 2%
Immunology and Microbiology 2 2%
Other 6 5%
Unknown 25 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 October 2022.
All research outputs
#4,932,966
of 25,837,817 outputs
Outputs from Clinical Cancer Research
#4,438
of 13,309 outputs
Outputs of similar age
#39,205
of 257,457 outputs
Outputs of similar age from Clinical Cancer Research
#41
of 148 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,309 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.8. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 257,457 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 148 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.